Atlas Trials

Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis

Clinical trial NCT03717961 · COMPLETED

Trial details

NCT number
NCT03717961
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Raynaud Phenomenon Secondary to Systemic Sclerosis
Start date
2018-10-15
Primary completion
2020-07-31
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.